Double-Blind Placebo-Controlled Trial of Digoxin in Symptomatic Paroxysmal Atrial Fibrillation
- 1 June 1999
- journal article
- clinical trial
- Published by Wolters Kluwer Health in Circulation
- Vol. 99 (21) , 2765-2770
Abstract
Background —Digoxin is commonly prescribed in symptomatic paroxysmal atrial fibrillation (AF) but has never been evaluated in this condition. Methods and Results —From a multicenter registry, 43 representative patients with frequent symptomatic AF episodes were recruited into a randomized, double-blind crossover comparison of digoxin (serum concentration, 1.29±0.35 nmol/L) and placebo. The study end point was the occurrence of 2 AF episodes (documented by patient-activated monitors), censored at 61 days. The median time to 2 episodes was 13.5 days on placebo and 18.7 days on digoxin ( P P P Conclusions —Digoxin reduces the frequency of symptomatic AF episodes. However, the estimated effect is small and may be due to a reduction in the ventricular rate or irregularity rather than an antiarrhythmic action.Keywords
This publication has 26 references indexed in Scilit:
- Effect of Digoxin on the Ventricular Rate Variability During Paroxysmal Atrial FibrillationPacing and Clinical Electrophysiology, 1996
- Safety and utility of flecainide acetate in the routine care of patients with supraventricular tachyarrhythmias: Results of a mmulticenter trialThe American Journal of Cardiology, 1996
- Early assessment by transesophageal echocardiography of left atrial appendage function after percutaneous mitral commissurotomyThe American Journal of Cardiology, 1996
- A randomized comparison of flecainide versus verapamil in paroxysmal supraventricular tachycardiaThe American Journal of Cardiology, 1996
- Prospective comparison of flecainide versus quinidine for the treatment of paroxysmal atrial fibrillation/flutterThe American Journal of Cardiology, 1996
- Identification of Atrial Fibrillation Episodes in Ambulatory Electrocardiographic Recordings: Validation of a Method for Obtaining Labeled R‐R Interval FilesPacing and Clinical Electrophysiology, 1995
- Correlation of symptoms with occurrence of paroxysmal supraventricular tachycardia or atrial fibrillation: A transtelephonic monitoring studyAmerican Heart Journal, 1992
- The analysis of failure time data in crossover studiesStatistics in Medicine, 1991
- Time of occurrence, duration, and ventricular rate of paroxysmal atrial fibrillation: the effect of digoxin.Heart, 1990
- Clinical features of paroxysmal atrial fibrillation an observation of 94 patients.Japanese Heart Journal, 1981